Legal briefing: Informed consent.
This issue's "Legal Briefing" column covers legal developments pertaining to informed consent. Not only has this topic been the subject of recent articles in this journal, but it also been the subject of numerous public and professional discussions over the past several months. Legal developments concerning informed consent can be usefully grouped into nine categories: 1. General disclosure standards in the clinical context; 2. Shared decision making; 3. Staturorily mandated abortion disclosures; 4. Staturorily mandated end-of-life counseling; 5. Other staturorily mandated subject-specific disclosures; 6. U.S. Food and Drug Administration (FDA) labeling and federal pre-emption of state informed consent law; 7. Relaxed informed consent for HIV testing; 8. General disclosure standards in the research context; 9. Issues on the horizon.
Pope
Thaddeus Mason
TM
Health Law Institute, Widener University School of Law, Wilmington, Delaware, USA. tmpope@widener.edu
D000028:Abortion, Induced; D002684:Chiropractic; D000529:Complementary Therapies; D003357:Cosmetic Techniques; D003376:Counseling; D003657:Decision Making / Q000941:ethics; D017048:Health Care Costs; D006801:Humans; D007231:Infant, Newborn; D007258:Informed Consent / Q000331:legislation & jurisprudence*; D016743:Mental Competency; D009276:Namibia; D015997:Neonatal Screening; D010358:Patient Participation; D012106:Research; D018154:Slovakia; D013727:Terminal Care; D014481:United States; D014486:United States Food and Drug Administration